The Chemours Company $CC Shares Purchased by Public Sector Pension Investment Board

Public Sector Pension Investment Board raised its position in The Chemours Company (NYSE:CC) by 14.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 583,947 shares of the specialty chemicals company’s stock after purchasing an additional 73,635 shares during the period. Public Sector Pension Investment Board’s holdings in Chemours were worth $9,250,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of CC. MTM Investment Management LLC purchased a new position in Chemours in the 2nd quarter valued at about $27,000. Evelyn Partners Asset Management Ltd acquired a new stake in Chemours during the second quarter worth about $37,000. FNY Investment Advisers LLC raised its holdings in Chemours by 100.0% in the second quarter. FNY Investment Advisers LLC now owns 4,000 shares of the specialty chemicals company’s stock valued at $45,000 after buying an additional 2,000 shares during the period. CWM LLC lifted its holdings in shares of Chemours by 34.7% during the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company’s stock valued at $49,000 after acquiring an additional 1,104 shares in the last quarter. Finally, Hantz Financial Services Inc. grew its stake in shares of Chemours by 334.2% in the third quarter. Hantz Financial Services Inc. now owns 4,329 shares of the specialty chemicals company’s stock valued at $69,000 after buying an additional 3,332 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CC has been the topic of a number of recent analyst reports. Royal Bank Of Canada reiterated an “outperform” rating and issued a $18.00 price objective on shares of Chemours in a report on Friday, January 16th. UBS Group lowered their price objective on shares of Chemours from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, November 11th. BMO Capital Markets reiterated an “outperform” rating and issued a $20.00 target price on shares of Chemours in a research note on Monday, January 19th. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a report on Wednesday, January 21st. Finally, Truist Financial raised their target price on shares of Chemours from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, January 21st. Five investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $16.67.

Chemours Stock Performance

Shares of NYSE CC opened at $20.48 on Tuesday. The business’s 50-day moving average price is $14.69 and its two-hundred day moving average price is $14.25. The Chemours Company has a one year low of $9.13 and a one year high of $21.85. The company has a market capitalization of $3.07 billion, a P/E ratio of -9.23 and a beta of 1.63. The company has a debt-to-equity ratio of 13.66, a current ratio of 1.71 and a quick ratio of 0.88.

About Chemours

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.